Titles
- Community health centers and Medicaid delivery and payment reform: a closer look at Massachusetts and New York1
- Community health centers and the President’s HIV Initiative: issues and challenges facing health centers in high-burden states and communities1
- Community health centers continue steady growth, but challenges loom1
- Comparing health insurance reform options: from "building on the ACA" to single payer1
- Compliance policy for certain compounding of oral oxitriptan (5-HTP) drug products for patients with tetrahydrobiopterin (BH4) deficiency: immediately in effect guidance for industry1
- Compliance policy for limited modifications to certain marketed tobacco products1
- Concerns about opioid use in Medicare Part D in the Appalachian region1
- Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff1
- Considerations for the development of dried plasma products intended for transfusion1
- Considerations for the inclusion of adolescent patients in adult oncology clinical trials1
- Considerations in demonstrating interchangeability with a reference product1
- Contraceptive access, choice, and utilization: a survey of Mississippi women1
- Contributors to post-injury mental health in urban black men with serious injuries1
- Coordinated development of antimicrobial drugs and antimicrobial susceptibility test devices: guidance for industry and Food and Drug Administration staff1
- Cost savings1
- Course corrections: how health care innovators learn from setbacks to achieve success1
- Defraying high out-of-pocket health care costs: the medical expense tax deduction1
- Delayed graft function in kidney transplantation: developing drugs for prevention1
- Delivery reform1
- Determining whether to submit an ANDA or a 505(b)(2) application1